Trial Profile
The effect of varying degrees of renal impairment on the single dose pharmacokinetic profile of orally administered lurasidone: a phase I study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Apr 2009
Price :
$35
*
At a glance
- Drugs Lurasidone (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Dainippon Sumitomo Pharma
- 30 Mar 2009 Planned number of patients changed from 33 to 24 as reported by ClinicalTrials.gov.
- 24 Feb 2009 New trial record